{"id":32614,"date":"2025-04-19T09:47:16","date_gmt":"2025-04-19T09:47:16","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/32614\/"},"modified":"2025-04-19T09:47:16","modified_gmt":"2025-04-19T09:47:16","slug":"patients-on-common-blood-pressure-drug-urged-to-check-pack-amid-labelling-error","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/32614\/","title":{"rendered":"Patients on common blood pressure drug urged to check pack amid labelling error"},"content":{"rendered":"<p>Patients who take a common drug for high blood pressure are being urged to check the medication after its manufacturer reported that a mistake in the strength of the dose had been printed on some packs.<\/p>\n<p>One batch of the medicine Lercanidipine, made by Recordati Pharmaceuticals, is labelled as containing 10mg tablets when it in fact contains 20mg.<\/p>\n<p>The correct strength is printed on the top of the carton and on the blister strips, according to an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA).<\/p>\n<p>Patients are being urged to check for the batch number MD4L07 with an expiry date of January 2028 as a \u201cprecautionary measure\u201d.<\/p>\n<p>More than 7,700 packs affected by the recall have been distributed, according to the MHRA.<\/p>\n<p>People who have already been prescribed medication from this batch should contact their GP or pharmacist immediately, or call NHS 111 if they cannot be reached.<\/p>\n<p>If speaking to a healthcare professional is not possible, the MHRA advises patients to check the strength of the tablet using the information on the foil of the blister strip.<\/p>\n<p>Those who have been prescribed 10mg should take half a 20mg tablet as a temporary measure until they can speak to their GP or pharmacist.<\/p>\n<p>Lercanidipine is a calcium channel blocker, which works by blocking calcium from entering the heart and blood vessel muscles, helping to relax blood vessels and reduce blood pressure.<\/p>\n<p>Taking too much can lead to a fast or irregular heartbeat, dizziness or sleepiness.<\/p>\n<p>Dr Alison Cave, chief safety officer at MHRA, said: \u201cPatient safety is our top priority. We ask patients to check their medicine packaging and follow our advice.<\/p>\n<p>\u201cHealthcare professionals such as pharmacists are also being asked to stop supplying medicine from the affected batch and to return it to the supplier.<\/p>\n<p>\u201cPlease report any suspected adverse reactions via the\u00a0MHRA\u2019s Yellow Card scheme.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Patients who take a common drug for high blood pressure are being urged to check the medication after&hellip;\n","protected":false},"author":2,"featured_media":32615,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[19214,1629,19217,105,4348,2750,19218,19213,6738,19216,19215,16,15],"class_list":{"0":"post-32614","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-batch-number","9":"tag-blood-pressure","10":"tag-blood-vessel","11":"tag-health","12":"tag-healthcare","13":"tag-high-blood-pressure","14":"tag-lercanidipine","15":"tag-mhra","16":"tag-patients","17":"tag-precautionary-measure","18":"tag-recordati-pharmaceuticals","19":"tag-uk","20":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114363999722539739","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/32614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=32614"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/32614\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/32615"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=32614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=32614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=32614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}